The Brooklyn organization, seeking new audiences and pushing boundaries, debuts Techne, four digital installations from the ...

Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy ...

A month has gone by since the last earnings report for Techne (TECH). Shares have added about 2.2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading ...

Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi ...

Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by ...

Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bio-Techne Corporation TECH is set to release its first-quarter fiscal 2025 results on Oct. 30, before the opening bell. The medical diagnostic testing provider posted adjusted earnings per share ...

MINNEAPOLIS, Nov. 6, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its market-leading portfolio to advance cancer research from target discovery to ...

This was the stock's fourth consecutive day of losses.

These stock picks stand to benefit most from developing artificial intelligence technologies as we move into 2025. We sell different types of products and services to both investment professionals ...